Alzheimer's Family Research

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

165 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-07-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a research study about how family members make research participation decisions for a relative with Alzheimer's or a related dementia. The purpose of this study is to learn more about how proxies (the family member who makes decisions for that relative), would think through decisions about whether to enroll their relative in studies for not-yet-approved medications for Alzheimer's Disease. The long-term goal of the study is to improve the way researchers inform families about clinical research studies and opportunities for participation. This study is being sponsored by the National Institute on Aging.

Study participants will be interviewed by a research staff member about research enrollment decisions for their relative. A number of standardized questionnaires will be administered. There is only one visit required. The interview lasts about three hours. The investigators will try to make it as convenient as possible for your schedule.

This is a non-intervention study. UCSF CHR # H58055-31168-02 v.1 Date: 012709

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* The researcher will interview you for about 3 hours in a private office.
* Study location: All these procedures will be done at Dr. Dunn's research offices at UCSF. If you prefer, we can conduct the interview at your home in or near the San Francisco bay area.
* You will be asked questions about your general background, and about how providing care for the person with Alzheimer's Disease has affected you. You will also be asked some basic questions about the person with Alzheimer's Disease (such as how well they are functioning; personal information will not be collected, however).
* Then, you will be given a consent form for an imaginary study related to Alzheimer Disease. An imaginary study means that it is not a real study, but it is a made-up one. You or your relative will not really participate in the study that is described in the consent form, because it is only imaginary and created just for this research.
* Then, you will be asked questions to measure how well you understood the information presented to you. For example, you will be asked about the procedures, risks and benefits.
* You will also be interviewed regarding your opinions and attitudes about research participation. If you give your permission, we will audiotape this interview to help us more accurately record this information. You may refuse to answer any of the questions that make you uncomfortable. You do not have to agree to be audio-taped to participate in this study.
* You will be given some tests designed to measure memory, attention and other thinking abilities. These tests are for research purposes only, and are not being used for any type of diagnostic purposes. The research purpose is to help us understand proxies' abilities to make decisions as caregivers for seriously ill patients.
* You will be asked questions about your mood and about caring for someone with dementia. You may refuse to answer and questions that make you uncomfortable.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Decision Making

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Proxies

A family member-caregiver (the medical decision-maker) for someone with Alzheimer's Disease. Must be the person who would be able to make decisions for someone with Alzheimer's disease about being in medical research.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A family member-caregiver (the medical decision-maker) for someone with Alzheimer's Disease
* Able to be interviewed in person in or around the San Francisco Bay Area
* Able to read and understand English

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laura B Dunn, MD

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCSF Langley Porter Institute, or at participant's home

San Francisco, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AD R01

Identifier Type: -

Identifier Source: org_study_id